Glucocorticoid- and protein kinase A-dependent transcriptome regulation in airway smooth muscle.

Glucocorticoids (GCs) and protein kinase A (PKA)-activating agents (beta-adrenergic receptor agonists) are mainstream asthma therapies based on their ability to prevent or reverse excessive airway smooth muscle (ASM) constriction. Their abilities to regulate another important feature of asthma--excessive ASM growth--are poorly understood. Recent studies have suggested that GCs render agents of inflammation such as IL-1 beta and TNF-alpha mitogenic to ASM, via suppression of (antimitogenic) induced cyclooxygenase-2-dependent PKA activity. To further explore the mechanistic basis of these observations, we assessed the effects of epidermal growth factor and IL-1 beta stimulation, and the modulatory effects of GC treatment and PKA inhibition, on the ASM transcriptome by microarray analysis. Results demonstrate that ASM stimulated with IL-1 beta, in a manner that is often cooperative with stimulation with epidermal growth factor, exhibit a profound capacity to function as immunomodulatory cells. Moreover, results implicate an important role for induced autocrine/paracrine factors (many whose regulation was minimally affected by GCs or PKA inhibition) as regulators of both airway inflammation and ASM growth. Induction of numerous chemokines, in conjunction with regulation of proteases and agents of extracellular matrix remodeling, is suggested as an important mechanism promoting upregulated G protein-coupled receptor signaling capable of stimulating ASM growth. Additional functional assays suggest that intracellular PKA plays a critical role in suppressing the promitogenic effects of induced autocrine factors in ASM. Finally, identification and comparison of GC- and PKA-sensitive genes in ASM provide insight into the complementary effects of beta-agonist/GC combination therapies, and suggest specific genes as important targets for guiding the development of new generations of GCs and adjunct asthma therapies.

[1]  C. Billington,et al.  Cooperative mitogenic signaling by G protein‐coupled receptors and growth factors is dependent on Gq/11 , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  M. Brauchle,et al.  Dexamethasone Is a Novel Potent Inducer of Connective Tissue Growth Factor Expression , 1998, The Journal of Biological Chemistry.

[3]  J. Benovic,et al.  Pharmacological inhibition of protein kinases in intact cells: antagonism of beta adrenergic receptor ligand binding by H-89 reveals limitations of usefulness. , 1999, The Journal of pharmacology and experimental therapeutics.

[4]  S. Naderi,et al.  Cyclic AMP inhibits translation of cyclin D3 in T lymphocytes at the level of elongation by inducing eEF2-phosphorylation. , 2003, Cellular signalling.

[5]  R. Panettieri,et al.  Is airway smooth muscle the "missing link" modulating airway inflammation in asthma? , 2008, Chest.

[6]  J. Benovic,et al.  Regulation of heterotrimeric G protein signaling in airway smooth muscle. , 2008, Proceedings of the American Thoracic Society.

[7]  S. Mundell,et al.  Arrestin Specificity for G Protein-coupled Receptors in Human Airway Smooth Muscle* 210 , 2001, The Journal of Biological Chemistry.

[8]  G. Omlor,et al.  Methylprednisolone and isoproterenol inhibit airway smooth muscle proliferation by separate and additive mechanisms. , 1996, Life sciences.

[9]  P. Stork,et al.  Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. , 2002, Trends in cell biology.

[10]  R. Vlahos,et al.  Interleukin‐1α and tumour necrosis factor‐α modulate airway smooth muscle DNA synthesis by induction of cyclo‐oxygenase‐2: inhibition by dexamethasone and fluticasone propionate , 1999 .

[11]  R. Panettieri,et al.  Cytokines regulate beta-2-adrenergic receptor responsiveness in airway smooth muscle via multiple PKA- and EP2 receptor-dependent mechanisms. , 2005, Biochemistry.

[12]  E. R. Dixon,et al.  Effect of dexamethasone on bovine airway smooth muscle cell proliferation. , 1999, The Journal of asthma : official journal of the Association for the Care of Asthma.

[13]  C. G. McVicker,et al.  Proliferative aspects of airway smooth muscle. , 2004, The Journal of allergy and clinical immunology.

[14]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[15]  J. Gulcher,et al.  Association Between IL-1 β /TNF- α –Induced Glucocorticoid-Sensitive Changes in Multiple Gene Expression and Altered Responsiveness in Airway Smooth Muscle , 2001 .

[16]  I. Adcock,et al.  Effects of interleukin-1beta, interleukin-13 and transforming growth factor-beta on gene expression in human airway smooth muscle using gene microarrays. , 2004, European journal of pharmacology.

[17]  Q. Hamid,et al.  CCR3 Expression and Function in Asthmatic Airway Smooth Muscle Cells 1 , 2005, The Journal of Immunology.

[18]  B. Frenkel,et al.  Gene expression profiling of glucocorticoid-inhibited osteoblasts. , 2004, Journal of molecular endocrinology.

[19]  A. Miller-Larsson,et al.  Advances in asthma and COPD treatment: combination therapy with inhaled corticosteroids and long-acting beta 2-agonists. , 2006, Current pharmaceutical design.

[20]  W. Powell,et al.  Interleukin-8: novel roles in human airway smooth muscle cell contraction and migration. , 2006, American journal of physiology. Cell physiology.

[21]  P. Vadiveloo,et al.  Beta2-adrenergic receptor agonists and cAMP arrest human cultured airway smooth muscle cells in the G(1) phase of the cell cycle: role of proteasome degradation of cyclin D1. , 1999, Molecular pharmacology.

[22]  R. Panettieri,et al.  Mitogenic Effects of Cytokines on Smooth Muscle Are Critically Dependent on Protein Kinase A and Are Unmasked by Steroids and Cyclooxygenase Inhibitors , 2008, Molecular Pharmacology.

[23]  L. Kirschner,et al.  Disruption of protein kinase a regulation causes immortalization and dysregulation of D-type cyclins. , 2005, Cancer research.

[24]  K. Vranizan,et al.  Gene expression patterns define key transcriptional events in cell-cycle regulation by cAMP and protein kinase A. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[25]  C. Funk,et al.  PKC‐dependent regulation of the receptor locus dominates functional consequences of cysteinyl leukotriene type 1 receptor activation , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  J. Foidart,et al.  Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. , 2006, European journal of pharmacology.

[27]  P. Farnworth,et al.  Follistatin steady state messenger ribonucleic acid levels in confluent cultures of a rat renal mesangial cell line are regulated by multiple factors. , 1992, Endocrinology.

[28]  Jeremy P T Ward,et al.  beta1-Integrins mediate enhancement of airway smooth muscle proliferation by collagen and fibronectin. , 2005, American journal of respiratory and critical care medicine.

[29]  Q. Hamid,et al.  Expression and Regulation of CCR1 by Airway Smooth Muscle Cells in Asthma1 , 2008, The Journal of Immunology.

[30]  C. Li,et al.  Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  T. Lee,et al.  Differential effects of extracellular matrix proteins on human airway smooth muscle cell proliferation and phenotype. , 2000, American journal of respiratory cell and molecular biology.

[32]  J. Beavo,et al.  Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. , 2007, Annual review of biochemistry.

[33]  D. Abraham,et al.  Prostacyclin derivatives prevent the fibrotic response to TGFβ2 by inhibiting the Ras/MEK/ERK pathway , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  A. Stewart,et al.  Extracellular matrix, integrins, and mesenchymal cell function in the airways. , 2006, Current drug targets.

[35]  J. Shelhamer,et al.  Influence of IFN-on gene expression in normal human bronchial epithelial cells : modulation of IFN-effects by dexamethasone , 2005 .

[36]  C. Billington,et al.  Cooperative regulation of p70S6 kinase by receptor tyrosine kinases and G protein-coupled receptors augments airway smooth muscle growth. , 2005, Biochemistry.

[37]  J. Hipp,et al.  GeneChips in stem cell research. , 2006, Methods in enzymology.

[38]  Rafael A. Irizarry,et al.  Stochastic Models Inspired by Hybridization Theory for Short Oligonucleotide Arrays , 2005, J. Comput. Biol..

[39]  S. Peters,et al.  Regulatory features of interleukin-1beta-mediated prostaglandin E2 synthesis in airway smooth muscle. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[40]  John W. Wilson,et al.  Collagen‐induced resistance to glucocorticoid anti‐mitogenic actions: a potential explanation of smooth muscle hyperplasia in the asthmatic remodelled airway , 2003, British journal of pharmacology.

[41]  C. Brightling,et al.  Airway smooth muscle and mast cell-derived CC chemokine ligand 19 mediate airway smooth muscle migration in asthma. , 2006, American journal of respiratory and critical care medicine.

[42]  A. Stewart,et al.  Regulation of human airway mesenchymal cell proliferation by glucocorticoids and beta2-adrenoceptor agonists. , 2006, Pulmonary pharmacology & therapeutics.

[43]  S. Ito,et al.  Mass-spectrometric identification of proteins detected in forskolin-stimulated Xenopus laevis oocytes using antibody against phospho-(Ser/Thr) cAMP-dependent protein kinase substrate. , 2007, Biomedical research.

[44]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[45]  John W. Wilson,et al.  Differential inhibition of thrombin- and EGF-stimulated human cultured airway smooth muscle proliferation by glucocorticoids. , 2003, Pulmonary pharmacology & therapeutics.

[46]  J. Benovic,et al.  Mechanisms of proliferation synergy by receptor tyrosine kinase and G protein-coupled receptor activation in human airway smooth muscle. , 2000, American journal of respiratory cell and molecular biology.

[47]  H. S. Sharma,et al.  Role of extracellular matrix and its regulators in human airway smooth muscle biology , 2006, Cell Biochemistry and Biophysics.

[48]  C. Jessus,et al.  Redundant pathways for Cdc2 activation in Xenopus oocyte: either cyclin B or Mos synthesis , 2006, EMBO reports.

[49]  Kathryn S. Lilley,et al.  Phosphorylation of elongation factor-2 kinase on serine 499 by cAMP-dependent protein kinase induces Ca(2+)/calmodulin-independent activity , 2001 .

[50]  P. Rothman,et al.  Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells , 2004 .

[51]  C. Billington,et al.  Mechanisms of cytokine effects on G protein-coupled receptor-mediated signaling in airway smooth muscle. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[52]  A. Stewart,et al.  The effect of glucocorticoids on proliferation of human cultured airway smooth muscle , 1995, British journal of pharmacology.

[53]  D. Deshpande,et al.  Targeting G protein-coupled receptor signaling in asthma. , 2006, Cellular signalling.